通过免疫蛋白质酶中的N-Degrons推进向蛋白质降解
Jack White1, Michael M Shahid1, Mohamed Eldeeb1
1Department of Chemistry, Illinois State University, Normal, Illinois, 61761, USA.
Chembiochem : a European journal of chemical biology
|March 12, 2026
概括
研究人员开发了一种使用"子"N-degron策略的新型蛋白质溶解向金氏体 (PROTAC). 这种方法利用免疫蛋白酶体 (iCP) 激活PROTACs,增强稳定性并使向蛋白质降解成为可能.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 化向化体 (PROTACs) 具有治疗潜力,但面临的是代谢不稳定性和选择性的挑战.
- 由于其结构,N-degron PROTACs容易过早降解和异于目标效应.
研究的目的:
- 开发一种新的 PROTAC 战略,增强功能稳定性并实现取决于环境的特异性.
- 为了设计一个由特定蛋白酶激活的N-degron PROTAC,用于向蛋白质降解.
主要方法:
- 引入一个"化"的N-degron PROTAC,其中一个四甲-形态素片段屏蔽了阿尔金因降解.
- 利用免疫蛋白质酶 (iCP),一种可诱导的蛋白质酶异型,进行蛋白质酶导入激活.
- 将PROTAC与达沙替尼结合在一起,以准ABL氨酸激酶降解.
主要成果:
- 中的N-degron PROTAC在ICP介导的裂变时显示出蛋白酶关口激活.
- 这一策略增强了功能稳定性,并为蛋白质降解提供了取决于背景的特异性.
- 通过这种免疫蛋白质酶门机制实现了ABL氨酸激酶的降解.
结论:
- 免疫蛋白酶受阻的PROTACs为下一代降解剂提供了一个有前途的框架.
- 蛋白酶导入策略整合了内源蛋白质溶解特异性,以改善降解剂激活.
- 需要进一步开发以解决细胞透性和疾病依赖的ICP表达.
相关概念视频
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
The Proteasome
1.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
The Proteasome
4.9K
4.9K
Regulated Protein Degradation
9.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.1K
Regulated Protein Degradation
3.3K
3.3K
The Proteasome Structure
2.0K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
2.0K


